Panion & Bf Biotech Inc. (1760.TW)
Taiwan · TWD · Healthcare · Drug Manufacturers - Specialty & Generic
NT$51.70 (-0.39%) as of
Key statistics
- Market cap
- 4.43B
- P/E (TTM)
- 20.60
- Forward P/E
- 29.38
- EPS (TTM)
- 2.51
- Dividend yield
- 3.48%
- 52-week range
- 51.50 – 76.40
- Beta
- -0.13
- Revenue (TTM)
- 2.11B
- Profit margin
- 10.19%
- Volume
- 21.32k
About Panion & Bf Biotech Inc.
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.